Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Abstract Background Histocompatibility minor 13 (HM13) is a signal sequence stubbed intramembrane cleavage catalytic protein that is essential for cell signaling, intracellular communication, and cancer. However, the expression of HM13 and its prognostic value, association with tumor-infiltrating im...

Full description

Bibliographic Details
Main Authors: Genhao Zhang, Xianping Lv, Qiankun Yang, Hongchun Liu
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Cancer
Subjects:
HM13
Prognosis
Immune checkpoint inhibitors
HCC
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-022-09987-2

Internet

https://doi.org/10.1186/s12885-022-09987-2

Similar Items